# OnCo record paper-chawla-jama-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-chawla-jama-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-chawla-jama-oncol" ;
  schema:name "First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial"@en ;
  schema:description "Paper cited by one trial page and one treatment page, indexed on Europe PMC as PubMed record 26378637 and published in JAMA Oncology; the citing pages link this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-chawla-jama-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2015.3101>, <https://pubmed.ncbi.nlm.nih.gov/26378637/>, <https://europepmc.org/article/MED/26378637> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1001/jamaoncol.2015.3101> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Chawla SP, Papai Z, Mukhametshina G, et al." ;
  onco:related <https://onco.cc/drugs/aldoxorubicin/> ;
  onco:trials <https://onco.cc/trials/aldoxorubicin-phase-3-sts/> ;
  onco:journals <https://onco.cc/journals/jama-oncology/> .